Primary Care Clinics in Mount Ida, AR Accepting Medicare
4 Primary Care Clinics found. Showing 1 - 4
 Chi St. Vincent Medical Group Hot Springs Family Medicine Medicare: Medicare Enrolled Practice Location: 320 Luzerne St, Mount Ida, AR 71957 Phone: 870-867-2175 Fax: 870-867-4050 |
Montgomery County Community Clinic Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 534 Luzerne St, Mount Ida, AR 71957 Phone: 870-867-4244 Fax: 870-867-4254 |
Healthy Connections, Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 338 Whittington St, Mount Ida, AR 71957 Phone: 888-710-8220 |
Healthy Connections, Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 430 Ballpark Rd, Mount Ida, AR 71957 Phone: 888-710-8220 |
News Archive
EU-funded project examines dietary habits in people with inadequate nutrition
Until now, we have had very little understanding of the extent of malnutrition in Europe, especially in populations at risk of poverty. Now, an EU-funded project calledCHANCE, aims to address the dietary habits in people with inadequate nutrition.
AYOXXA to develop multiplex immunoassay to support treatment of sepsis patients
AYOXXA Biosystems GmbH, an international biotechnology company, will develop a multiplex assay to support the treatment of sepsis patients as part of the project "SepsisData.Net.NRW - Digitized Pattern Recognition for Personalized Treatment of Sepsis Patients". The development will be based on the Company's innovative bead-based protein analysis platform LUNARIS™.
EPA continues to validate ToxCast screening tool by testing more than 100 drugs
The U.S. Environmental Protection Agency will continue validating its ToxCast screening tool by screening more than 100 drugs provided by Pfizer, GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered the marketplace because they demonstrated different types and levels of toxicity when the pharmaceutical companies conducted the early stage clinical trials required by the Food and Drug Administration as part of the drug development process.
Researchers develop optimised PSA screening programme for prostate cancer
As an indicator of prostate cancer, the PSA test is regarded in urology as highly controversial since it is not always unequivocal. A team of researchers from the Comprehensive Cancer Center at the MedUni Vienna and Vienna General Hospital has now developed a programme that compensates the shortfalls of PSA screening with methods from personalised medicine. As a result, prostate cancer screening is able to reach a new level of quality.
› Verified 3 days ago